Cargando…
DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions
DLC1 (Deleted in Liver Cancer 1) gene encodes a RhoGTPase-activating protein (RhoGAP), which exerts most of its tumor suppressor functions through suppression of small Rho GTPases proteins RhoA, RhoB, RhoC and to some degree Cdc42, but not Rac. RhoGTPases are implicated in NF-κB activation in highly...
Autores principales: | Tripathi, Veenu, Popescu, Nicholas C, Zimonjic, Drazen B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967735/ https://www.ncbi.nlm.nih.gov/pubmed/24683532 http://dx.doi.org/10.1186/2193-1801-3-27 |
Ejemplares similares
-
Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics
por: ZIMONJIC, DRAZEN B., et al.
Publicado: (2012) -
DLC-1:a Rho GTPase-activating protein and tumour suppressor
por: Durkin, Marian E, et al.
Publicado: (2007) -
The RhoGAP protein Deleted in Liver Cancer 3 (DLC3) is essential for adherens junctions integrity
por: Holeiter, G, et al.
Publicado: (2012) -
Acquired genetic and functional alterations associated with transforming growth factor β type I resistance in Hep3B human hepatocellular carcinoma cell line
por: Zimonjic, Drazen B, et al.
Publicado: (2009) -
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
por: Zimonjic, Drazen B, et al.
Publicado: (2013)